[1]
R. Munshi, S. Gaikwad, and M. Maurya, “Association of hyperglycemia with Tenofovir+Lamivudine+Dolutegravir (TLD) or Tenofovir+Lamivudine+Efavirenz (TLE) antiretroviral regimens in patients living with HIV: a retrospective cohort study”., The Nig Health J, vol. 25, no. 2, pp. 561–569, Jun. 2025, doi: 10.71637/tnhj.v25i2.949.